Carregant...

In vitro metabolism of misonidazole.

Misonidazole (MISO) is a nitroimidazole drug currently undergoing clinical trials as a radiosensitizer of hypoxic tumour cells. The drug is also toxic to such cells, probably because of metabolic activation of the nitro group under hypoxia. The metabolic fate of 14C-labelled MISO is examined, using...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Josephy, P. D., Palcic, B., Skarsgard, L. D.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 1981
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2010618/
https://ncbi.nlm.nih.gov/pubmed/7236487
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!